Sg Americas Securities, LLC Enanta Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$10.08 - $17.46 $26,087 - $45,186	-2,588 Reduced 25.47%	7,574 $132,000
Q4 2023 Jan 12, 2024	SELL	$8.18 - $10.78 $68,581 - $90,379	-8,384 Reduced 45.21%	10,162 $96,000
Q3 2023 Oct 13, 2023	SELL	$11.09 - $22.13 $455,677 - $909,299	-41,089 Reduced 68.9%	18,546 $207,000
Q2 2023 Jul 10, 2023	BUY	$20.68 - $39.85 $356,150 - $686,296	17,222 Added 40.61%	59,635 $1.28 Million
Q1 2023 Apr 28, 2023	BUY	$38.82 - $54.59 $899,265 - $1.26 Million	23,165 Added 120.35%	42,413 $1.72 Million
Q4 2022 Feb 02, 2023	BUY	$40.77 - $53.73 $440,927 - $581,089	10,815 Added 128.25%	19,248 $895,000
Q3 2022 Oct 31, 2022	SELL	$48.29 - $71.27 $793,646 - $1.17 Million	-16,435 Reduced 66.09%	8,433 $437,000
Q2 2022 Jul 29, 2022	SELL	$38.13 - $76.93 $82,093 - $165,630	-2,153 Reduced 7.97%	24,868 $1.18 Million
Q1 2022 Apr 29, 2022	BUY	$56.06 - $74.11 $1.35 Million - $1.79 Million	24,153 Added 842.15%	27,021 $1.92 Million
Q4 2021 Feb 07, 2022	SELL	$60.19 - $97.37 $3.02 Million - $4.88 Million	-50,131 Reduced 94.59%	2,868 $214,000
Q3 2021 Nov 01, 2021	BUY	$41.02 - $58.65 $296,369 - $423,746	7,225 Added 15.78%	52,999 $3.01 Million
Q2 2021 Aug 12, 2021	SELL	$43.76 - $53.11 $137,931 - $167,402	-3,152 Reduced 6.44%	45,774 $2.02 Million
Q1 2021 May 13, 2021	BUY	$41.69 - $54.95 $136,034 - $179,301	3,263 Added 7.15%	48,926 $2.41 Million
Q4 2020 Feb 04, 2021	BUY	$41.16 - $47.47 $390,649 - $450,537	9,491 Added 26.24%	45,663 $1.92 Million
Q3 2020 Nov 09, 2020	BUY	$43.36 - $53.53 $1 Million - $1.24 Million	23,113 Added 176.99%	36,172 $1.66 Million
Q2 2020 Jul 20, 2020	BUY	$46.37 - $57.58 $402,259 - $499,506	8,675 Added 197.88%	13,059 $656,000
Q1 2020 Apr 30, 2020	SELL	$40.22 - $62.0 $84,984 - $131,006	-2,113 Reduced 32.52%	4,384 $225,000
Q4 2019 Jan 28, 2020	SELL	$57.95 - $66.61 $610,155 - $701,336	-10,529 Reduced 61.84%	6,497 $401,000
Q3 2019 Nov 04, 2019	BUY	$60.08 - $88.17 $943,075 - $1.38 Million	15,697 Added 1181.11%	17,026 $1.02 Million
Q2 2019 Jul 29, 2019	SELL	$81.3 - $97.35 $50,731 - $60,746	-624 Reduced 31.95%	1,329 $112,000
Q1 2019 Apr 29, 2019	SELL	$69.08 - $105.66 $342,360 - $523,650	-4,956 Reduced 71.73%	1,953 $187,000
Q4 2018 Feb 01, 2019	BUY	$65.41 - $84.65 $451,917 - $584,846	6,909 New	6,909 $489,000
Q3 2018 Nov 06, 2018	SELL	$85.46 - $126.37 $153,400 - $226,834	-1,795 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$81.85 - $120.51 $33,149 - $48,806	405 Added 29.14%	1,795 $208,000
Q1 2018 May 03, 2018	BUY	$57.91 - $92.15 $80,494 - $128,088	1,390 New	1,390 $112,000
Q4 2017 Jan 24, 2018	SELL	$45.65 - $59.37 $258,470 - $336,152	-5,662 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$37.91 - $46.8 $214,646 - $264,981	5,662	5,662 $265,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$18 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$17 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$15.8 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$12.8 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$9.44 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account